DeepMed Research

TUFTS MEDICAL CENTER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

Phase 1

Completed

Conditions: Vascular Disease
Coronary Artery Disease Risk Factors Multiple

Interventions: Drug: PZ-128

First Posted Date: 2013-03-07

Last Posted Date: 2016-04-21

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 32

Registration Number: NCT01806077

Locations: 🇺🇸
Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research), Baltimore, Maryland, United States

Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Prasugrel
Drug: Clopidogrel

First Posted Date: 2013-02-12

Last Posted Date: 2017-04-04

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 24

Registration Number: NCT01789814

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants

Phase 2

Terminated

Conditions: Bronchopulmonary Dysplasia

Interventions: Drug: inhaled nitric oxide
Drug: Placebo Comparator - nitrogen gas

First Posted Date: 2012-12-12

Last Posted Date: 2017-07-19

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 3

Registration Number: NCT01748045

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Vitamin D for Established Type 2 Diabetes (DDM2)

Phase 2

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Cholecalciferol

First Posted Date: 2012-11-29

Last Posted Date: 2020-04-01

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 127

Registration Number: NCT01736865

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸
Cincinnati VA Medical Center, Cincinnati, Ohio, United States

Metabolic Abnormalities in HIV-infected Persons

Phase 4

Completed

Conditions: HIV Infection
Lipodystrophy

Interventions: Drug: Metformin
Drug: Pioglitazone

First Posted Date: 2012-06-06

Last Posted Date: 2016-06-20

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 20

Registration Number: NCT01612858

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

Phase 1

Terminated

Conditions: Chronic Lymphocytic Leukemia
Lymphoma
Multiple Myeloma

Interventions: Drug: Plerixafor

First Posted Date: 2012-06-04

Last Posted Date: 2017-05-09

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 7

Registration Number: NCT01610999

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea

Completed

Conditions: Metabolic Syndrome
Sleep Apnea

First Posted Date: 2012-06-04

Last Posted Date: 2016-04-21

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 258

Registration Number: NCT01610648

Locations: 🇺🇸
Sleep Center, Tufts Medical Center, Boston, Massachusetts, United States

Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: Neurofeedback
Other: Waitlist Control
Behavioral: Cognitive Training

First Posted Date: 2012-04-24

Last Posted Date: 2017-07-07

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 104

Registration Number: NCT01583829

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

Phase 4

Completed

Conditions: Cutaneous Abscess

Interventions: Drug: Chlorhexidine gluconate
Drug: Mupirocin

First Posted Date: 2012-02-23

Last Posted Date: 2017-04-13

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 50

Registration Number: NCT01537783

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: Metformin

First Posted Date: 2011-09-29

Last Posted Date: 2017-05-09

Lead Sponsor: Tufts Medical Center

Target Recruit Count: 105

Registration Number: NCT01442870

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy